Richard Veselý

2.0k total citations
15 papers, 322 citations indexed

About

Richard Veselý is a scholar working on Speech and Hearing, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Richard Veselý has authored 15 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Speech and Hearing, 7 papers in Hematology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Richard Veselý's work include Adolescent and Pediatric Healthcare (8 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Pharmaceutical studies and practices (4 papers). Richard Veselý is often cited by papers focused on Adolescent and Pediatric Healthcare (8 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Pharmaceutical studies and practices (4 papers). Richard Veselý collaborates with scholars based in United States, Slovakia and Italy. Richard Veselý's co-authors include Alberto Martini, Nicolino Ruperto, Sandra L. Kweder, Joost P.H. Drenth, J.W.M. van der Meer, Kazuya Yoshimura, Urban Myrdal, Anna Simon, Rubén Burgos‐Vargas and Angela Pistorio and has published in prestigious journals such as Gastroenterology, Anesthesiology and Annals of the Rheumatic Diseases.

In The Last Decade

Richard Veselý

14 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Veselý United States 8 148 113 81 77 51 15 322
Ruth Costello United Kingdom 11 52 0.4× 22 0.2× 15 0.2× 24 0.3× 50 1.0× 23 338
Christine A. Johnson United States 9 105 0.7× 33 0.3× 47 0.6× 22 0.3× 17 0.3× 14 293
Arvind Nagra United Kingdom 7 31 0.2× 126 1.1× 107 1.3× 23 0.3× 48 0.9× 14 273
Emily Herreshoff United States 9 15 0.1× 28 0.2× 46 0.6× 23 0.3× 20 0.4× 15 240
Amie E. Hwang United States 9 10 0.1× 29 0.3× 125 1.5× 49 0.6× 35 0.7× 31 330
David J. Valacer United States 8 16 0.1× 10 0.1× 40 0.5× 20 0.3× 63 1.2× 15 485
Anna Medyńska Poland 10 14 0.1× 70 0.6× 79 1.0× 18 0.2× 18 0.4× 31 233
Sadamu Okada Japan 9 109 0.7× 11 0.1× 9 0.1× 24 0.3× 28 0.5× 29 319
Eugene Suh United States 6 30 0.2× 77 0.7× 270 3.3× 25 0.3× 6 0.1× 9 385
Valgerður Sigurðardóttir Sweden 9 19 0.1× 5 0.0× 33 0.4× 38 0.5× 55 1.1× 25 367

Countries citing papers authored by Richard Veselý

Since Specialization
Citations

This map shows the geographic impact of Richard Veselý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Veselý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Veselý more than expected).

Fields of papers citing papers by Richard Veselý

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Veselý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Veselý. The network helps show where Richard Veselý may publish in the future.

Co-authorship network of co-authors of Richard Veselý

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Veselý. A scholar is included among the top collaborators of Richard Veselý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Veselý. Richard Veselý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mulberg, Andrew E., Laurie S. Conklin, Nicholas M. Croft, et al.. (2022). Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug Development. Gastroenterology. 163(1). 77–83. 3 indexed citations
2.
Veselý, Richard, et al.. (2019). A Comparison of EMA and FDA Decisions for New Drug Marketing Applications 2014–2016: Concordance, Discordance, and Why. Clinical Pharmacology & Therapeutics. 107(1). 195–202. 65 indexed citations
3.
Stefańska, Anna, Kristina Dunder, Tomas Salmonson, et al.. (2017). Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases. Archives of Disease in Childhood. 102(10). 952–957. 7 indexed citations
4.
Sun, Haihao, et al.. (2016). Pediatric Crohn Disease Clinical Outcome Assessments and Biomarkers. Journal of Pediatric Gastroenterology and Nutrition. 64(3). 368–372. 5 indexed citations
5.
Sun, Haihao, Richard Veselý, Robert M. Nelson, et al.. (2014). Steps Toward Harmonization for Clinical Development of Medicines in Pediatric Ulcerative Colitis—A Global Scientific Discussion, Part 2. Journal of Pediatric Gastroenterology and Nutrition. 58(6). 684–688. 11 indexed citations
6.
Sun, Haihao, Richard Veselý, Jan Taminiau, et al.. (2014). Steps Toward Harmonization for Clinical Development of Medicines in Pediatric Ulcerative Colitis—A Global Scientific Discussion, Part 1. Journal of Pediatric Gastroenterology and Nutrition. 58(6). 679–683. 7 indexed citations
7.
Ruperto, Nicolino, Richard Veselý, Agnès Saint-Raymond, & Alberto Martini. (2013). Impact of the European paediatric legislation in paediatric rheumatology: past, present and future. Annals of the Rheumatic Diseases. 72(12). 1893–1896. 18 indexed citations
8.
Consolaro, Alessandro, Nicolino Ruperto, Angela Pistorio, et al.. (2011). Development and initial validation of composite parent‐ and child‐centered disease assessment indices for juvenile idiopathic arthritis. Arthritis Care & Research. 63(9). 1262–1270. 19 indexed citations
9.
Gutiérrez-Suárez, Raúl, Angela Pistorio, Ximena Norambuena, et al.. (2006). Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Lara D. Veeken. 46(2). 314–320. 106 indexed citations
10.
Vargová, Veronika & Richard Veselý. (2005). Idiopatické muskuloskeletálne bolestivé syndrómy u detí. Pediatrie pro praxi. 3(2). 67–70. 1 indexed citations
11.
Simon, Anna, J.W.M. van der Meer, Richard Veselý, et al.. (2005). Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Lara D. Veeken. 45(3). 269–273. 54 indexed citations
12.
Veselý, Richard, Veronika Vargová, Angelo Ravelli, et al.. (2004). Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.. PubMed. 31(4). 795–800. 18 indexed citations
13.
Veselý, Richard, et al.. (2002). The Slovak version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ).. PubMed. 19(4 Suppl 23). S136–40. 1 indexed citations
14.
Vargová, Veronika, et al.. (1998). [Will administration of omega-3 unsaturated fatty acids reduce the use of nonsteroidal antirheumatic agents in children with chronic juvenile arthritis?].. PubMed. 137(21). 651–3. 4 indexed citations
15.
Veselý, Richard, et al.. (1987). The Cerebrovascular Effects of Curare and Histamine in the Rat. Anesthesiology. 66(4). 519–523. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Costello Breakdown of academic impact, for papers by Christine A. Johnson Breakdown of academic impact, for papers by Arvind Nagra Breakdown of academic impact, for papers by Emily Herreshoff Breakdown of academic impact, for papers by Amie E. Hwang Breakdown of academic impact, for papers by David J. Valacer Breakdown of academic impact, for papers by Anna Medyńska Breakdown of academic impact, for papers by Sadamu Okada Breakdown of academic impact, for papers by Eugene Suh Breakdown of academic impact, for papers by Valgerður Sigurðardóttir
Rankless by CCL
2026